The research community consensus, articulated in recent systematic reviews, states that BPC-157 should be considered investigational and approached with appropriate caution, but this recommendation stems from limited human clinical data rather than evidence of harm
Transcript Philip Pape: 0:01 If you're curious about BPC-157 or any other peptides or supplements for injury recovery and you want the truth about what I learned using it for my shoulder, but, more importantly, if you've ever tried self-experimentation and struggled to figure out whether something is actually working or not, this episode is for you
ALA: This ingredient has strong antioxidant properties, which may reduce inflammation and skin aging, promote healthy nerve function, lower heart disease risk factors, and slow the progression of memory loss disorders
Suspected adverse reactions to retatrutide within a trial should be reported to the trial team and can also be submitted to the MHRA via the Yellow Card scheme
